NAV

Potassium metabisulfite

This drug entry is astuband has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Potassium metabisulfite
DrugBank Accession Number
DB15841
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
MOL SDF PDB SMILES InChI
Similar Structures
Weight
Average: 222.31
Monoisotopic: 221.84612843
Chemical Formula
K2O5S2
Synonyms
  • Potassium disulfite
  • Potassium metabisulfite
  • Potassium metabisulphite
  • Potassium pentaoxodisulfate
  • Potassium pyrosulfite
External IDs
  • E-224
  • INS NO.224
  • INS-224

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
这些信息不应该被解释the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image
PROCALAMINE INJECTION Potassium metabisulfite(<0.05 g/100 ml)+Alanine(0.21 g/100ml)+Arginine(0.29 g/100ml)+Calcium acetate(0.026 g/100ml)+Cysteine(<0.014 g/100 ml)+Glycerin(3 g/100ml)+Glycine(0.42 g/100ml)+Histidine(0.085 g/100ml)+Isoleucine(0.21 g/100ml)+Leucine(0.27 g/100ml)+Lysine acetate(0.22 g/100ml)+Magnesium acetate(0.054 g/100ml)+Methionine(0.16 g/100ml)+Phenylalanine(0.17 g/100ml)+Phosphoric acid(0.041 g/100ml)+Potassium chloride(0.15 g/100ml)+Proline(0.34 g/100ml)+Serine(0.18 g/100ml)+Sodium acetate(0.2 g/100ml)+Sodium chloride(0.12 g/100ml)+Threonine(0.12 g/100ml)+Tryptophan(0.046 g/100ml)+Valine(0.2 g/100ml) Injection Intravenous B. BRAUN SINGAPORE PTE LTD 1995-06-29 Not applicable
PROCALAMINE SISE 1000 ML(SETSIZ) Potassium metabisulfite(0.05 g/100ml)+Alanine(0.21 g/100ml)+Arginine(0.29 g/100ml)+Calcium acetate monohydrate(0.026 g/100ml)+Cysteine hydrochloride(0.02 g/100ml)+Glycerin(3 g/100ml)+Glycine(0.42 g/100ml)+Histidine(0.085 g/100ml)+Isoleucine(0.21 g/100ml)+Leucine(0.27 g/100ml)+Lysine(0.22 g/100ml)+Magnesium acetate tetrahydrate(0.054 g/100ml)+Methionine(0.16 g/100ml)+Phenylalanine(0.17 g/100ml)+Phosphoric acid(0.041 g/100ml)+Potassium chloride(0.149 g/100ml)+Proline(0.34 g/100ml)+Serine(0.18 g/100ml)+Sodium acetate trihydrate(0.204 g/100ml)+Sodium chloride(0.117 g/100ml)+Threonine(0.12 g/100ml)+Tryptophan(0.046 g/100ml)+Valine(0.2 g/100ml) Solution Parenteral ECZACIBAŞI-BAXTER HASTANE ÜRÜNLERİ SAN.VE TİC. A.Ş. 2020-08-14 2017-11-02 Turkey flag
Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image
PROCALAMINE SISE 1000 ML(SETLI) Potassium metabisulfite(0.05 g/100ml)+Alanine(0.21 g/100ml)+Arginine(0.29 g/100ml)+Calcium acetate monohydrate(0.026 g/100ml)+Cysteine hydrochloride(0.02 g/100ml)+Glycerin(3 g/100ml)+Glycine(0.42 g/100ml)+Histidine(0.085 g/100ml)+Isoleucine(0.21 g/100ml)+Leucine(0.27 g/100ml)+Lysine(0.22 g/100ml)+Magnesium acetate tetrahydrate(0.054 g/100ml)+Methionine(0.16 g/100ml)+Phenylalanine(0.17 g/100ml)+Phosphoric acid(0.041 g/100ml)+Potassium chloride(0.149 g/100ml)+Proline(0.34 g/100ml)+Serine(0.18 g/100ml)+Sodium acetate trihydrate(0.204 g/100ml)+Sodium chloride(0.117 g/100ml)+Threonine(0.12 g/100ml)+Tryptophan(0.046 g/100ml)+Valine(0.2 g/100ml) Solution Parenteral ECZACIBAŞI-BAXTER HASTANE ÜRÜNLERİ SAN.VE TİC. A.Ş. 2020-08-14 Not applicable Turkey flag
PROCALAMINE SISE 500 ML(SETLI) Potassium metabisulfite(0.05 g/100ml)+Alanine(0.21 g/100ml)+Arginine(0.29 g/100ml)+Calcium acetate monohydrate(0.026 g/100ml)+Cysteine hydrochloride(0.02 g/100ml)+Glycerin(3 g/100ml)+Glycine(0.42 g/100ml)+Histidine(0.085 g/100ml)+Isoleucine(0.21 g/100ml)+Leucine(0.27 g/100ml)+Lysine(0.22 g/100ml)+Magnesium acetate tetrahydrate(0.054 g/100ml)+Methionine(0.16 g/100ml)+Phenylalanine(0.17 g/100ml)+Phosphoric acid(0.041 g/100ml)+Potassium chloride(0.149 g/100ml)+Proline(0.34 g/100ml)+Serine(0.18 g/100ml)+Sodium acetate trihydrate(0.204 g/100ml)+Sodium chloride(0.117 g/100ml)+Threonine(0.12 g/100ml)+Tryptophan(0.046 g/100ml)+Valine(0.2 g/100ml) Solution Parenteral ECZACIBAŞI-BAXTER HASTANE ÜRÜNLERİ SAN.VE TİC. A.Ş. 2020-08-14 Not applicable Turkey flag
PROCALAMINE SISE 500 ML(SETSIZ) Potassium metabisulfite(0.05 g/100ml)+Alanine(0.21 g/100ml)+Arginine(0.29 g/100ml)+Calcium acetate monohydrate(0.026 g/100ml)+Cysteine hydrochloride(0.02 g/100ml)+Glycerin(3 g/100ml)+Glycine(0.42 g/100ml)+Histidine(0.085 g/100ml)+Isoleucine(0.21 g/100ml)+Leucine(0.27 g/100ml)+Lysine(0.22 g/100ml)+Magnesium acetate tetrahydrate(0.054 g/100ml)+Methionine(0.16 g/100ml)+Phenylalanine(0.17 g/100ml)+Phosphoric acid(0.041 g/100ml)+Potassium chloride(0.149 g/100ml)+Proline(0.34 g/100ml)+Serine(0.18 g/100ml)+Sodium acetate trihydrate(0.204 g/100ml)+Sodium chloride(0.117 g/100ml)+Threonine(0.12 g/100ml)+Tryptophan(0.046 g/100ml)+Valine(0.2 g/100ml) Solution Parenteral ECZACIBAŞI-BAXTER HASTANE ÜRÜNLERİ SAN.VE TİC. A.Ş. 2020-08-14 Not applicable Turkey flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
65OE787Q7W
CAS number
16731-55-8
InChI Key
RWPGFSMJFRPDDP-UHFFFAOYSA-L
InChI
InChI=1S/2K.H2O5S2/c;;1-6(2)7(3,4)5/h;;(H,1,2)(H,3,4,5)/q2*+1;/p-2
IUPAC Name
dipotassium sulfinatosulfonate
SMILES
[K+].[K+].[O-]S(=O)S([O-])(=O)=O

References

通用再保险公司ferences
Not Available
ChemSpider
26061
RxNav
1362899
ChEMBL
CHEMBL2106901
Wikipedia
Potassium_metabisulfite

Clinical Trials

Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Form Route Strength
Injection Intravenous 0.21 g/100ml
Solution Parenteral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Property Value Source
logP -1.6 Chemaxon
pKa (Strongest Acidic) -2.7 Chemaxon
Physiological Charge -2 Chemaxon
Hydrogen Acceptor Count 5 Chemaxon
Hydrogen Donor Count 0 Chemaxon
Polar Surface Area 97.33 Å2 Chemaxon
Rotatable Bond Count 1 Chemaxon
Refractivity 18.73 m3·mol-1 Chemaxon
Polarizability 9.14 Å3 Chemaxon
Number of Rings 0 Chemaxon
Bioavailability 1 Chemaxon
Rule of Five Yes Chemaxon
Ghose Filter No Chemaxon
Veber's Rule No Chemaxon
MDDR-like Rule No Chemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created at September 16, 2020 16:30 / Updated at September 16, 2020 21:10